Peripheral Nerve Stimulators (PNS) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Peripheral Nerve Stimulators (PNS) Pipeline Market Report Overview

A PNS is a device similar to the SCS, that is used to treat chronic pain disorders. A PNS is comprised of an electrical pacemaker that stimulates the peripheral nerve through the surgically implanted electrodes. The PNS pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Rechargeable Peripheral Nerve Stimulators

·       Non-Rechargeable Peripheral Nerve Stimulators

Key Territories ·       The US

·       China

·       South Korea

·       Europe

·       Canada

Key Regulatory Paths ·       PMA

·       NMPA

·       510(k)

·       CE

·       de novo

Leading Companies ·       Axonic SAS

·       Beijing Leading Medical Valley Technology Development Co Ltd

·       Bioness Inc

·       Cardionomic Inc

·       Coloplast A/S

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

PNS Pipeline Market by Segments

The key segments of the PNS pipeline market are rechargeable peripheral nerve stimulators and non-rechargeable peripheral nerve stimulators. As of September 2024, rechargeable peripheral nerve stimulators accounted for the highest share of pipeline products.

PNS Pipeline Market Analysis by Segments, 2024 (%)

PNS Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Peripheral Nerve Stimulators Pipeline Market

Download a Free Report Sample

PNS Pipeline Market Segmentation by Territories

A few of the key territories with the PNS pipeline market are the US, China, South Korea, Europe, and Canada. As of September 2024, the US accounted for the highest number of pipeline products.

PNS Pipeline Market Analysis by Territories, 2024 (%)

PNS Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Peripheral Nerve Stimulators Pipeline Market

Download a Free Report Sample

PNS Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the PNS pipeline products market are PMA, NMPA, 510(k), CE,  and de novo. As of September 2024, PMA was the most followed pathway for pipeline products in the PNS market.

PNS Pipeline Market Analysis by Regulatory Paths, 2024 (%)

PNS Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Peripheral Nerve Stimulators (PNS) Pipeline Market

Download a Free Report Sample

PNS Pipeline Market – Competitive Landscape

A few of the key companies associated with the PNS pipeline market are Axonic SAS, Beijing Leading Medical Valley Technology Development Co Ltd, Bioness Inc., Cardionomic Inc., and Coloplast A/S, among others.

Axonic SAS: Headquartered in Nice, Alpes-Côte d’Azur, France, it is a research and development company. Its product portfolio includes neurostimulation devices and the company also provides clinical tests. Axonic has business partnerships with Inria, Eurobiomed, Lirmm, Universite Nice Sophie Antipolis, Universite Cote Dazur, Cea, among others. The company has research centers such as CEA, INRIA, IPMC, LIRMM and has collaboration with university hospital professors and international companies.

Beijing Leading Medical Valley Technology Development Co Ltd: Headquartered in Beijing, China, it is a medical device company that engages in developing technologies for implantable neuroelectric stimulation to treat neurological functioning disorders.

PNS Pipeline Market Analysis by Companies, 2024

PNS Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Peripheral Nerve Stimulators (PNS) Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Peripheral Nerve Stimulators (PNS) Pipeline Market Segments Outlook (2024)

  • Rechargeable Peripheral Nerve Stimulators
  • Non-Rechargeable Peripheral Nerve Stimulators

Peripheral Nerve Stimulators (PNS) Pipeline Market Territories Outlook (2024)

  • The US
  • China
  • South Korea
  • Europe
  • Canada

Peripheral Nerve Stimulators (PNS) Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • NMPA
  • 510(k)
  • CE
  • de novo

Scope

This report provides:

  • Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Peripheral Nerve Stimulators (PNS) and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Axonic SAS
Beijing Leading Medical Valley Technology Development Co Ltd
Bioness Inc
Cardionomic Inc
Coloplast A/S
EBT Medical Inc
Evonik Corp
Hangzhou Shenluo Medical Technology Co Ltd
Medtronic Plc
MicroTransponder Inc
Nervonik Inc
Neurolief Ltd.
Neuros Medical Inc
Neurostream Technologies G.P. (Inactive)
Ripple LLC
SPR Therapeutics LLC
University of Utah
Uro Medical Corp
Valencia Technologies Corp
Washington University School of Medicine

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Peripheral Nerve Stimulators (PNS) Overview

3 Products under Development

3.1 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development

3.2 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Segment

3.3 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Territory

3.4 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Regulatory Path

3.5 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Estimated Approval Date

3.6 Peripheral Nerve Stimulators (PNS) – Ongoing Clinical Trials

4 Peripheral Nerve Stimulators (PNS) – Pipeline Products under Development by Companies

4.1 Peripheral Nerve Stimulators (PNS) Companies – Pipeline Products by Stage of Development

4.2 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development

5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview

5.1 Axonic SAS Company Overview

5.1.1 Axonic SAS Pipeline Products & Ongoing Clinical Trials Overview

5.2 Beijing Leading Medical Valley Technology Development Co Ltd Company Overview

5.2.1 Beijing Leading Medical Valley Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.3 Bioness Inc Company Overview

5.3.1 Bioness Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Cardionomic Inc Company Overview

5.4.1 Cardionomic Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Coloplast A/S Company Overview

5.5.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview

5.6 EBT Medical Inc Company Overview

5.6.1 EBT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Evonik Corp Company Overview

5.7.1 Evonik Corp Pipeline Products & Ongoing Clinical Trials Overview

5.8 Hangzhou Shenluo Medical Technology Co Ltd Company Overview

5.8.1 Hangzhou Shenluo Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.9 Medtronic Plc Company Overview

5.9.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.10 MicroTransponder Inc Company Overview

5.10.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 Nervonik Inc Company Overview

5.11.1 Nervonik Inc Pipeline Products & Ongoing Clinical Trials Overview

5.12 Neurolief Ltd. Company Overview

5.12.1 Neurolief Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.13 Neuros Medical Inc Company Overview

5.13.1 Neuros Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Neurostream Technologies G.P. (Inactive) Company Overview

5.14.1 Neurostream Technologies G.P. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.15 Ripple LLC Company Overview

5.15.1 Ripple LLC Pipeline Products & Ongoing Clinical Trials Overview

5.16 SPR Therapeutics LLC Company Overview

5.16.1 SPR Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.17 University of Utah Company Overview

5.17.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview

5.18 Uro Medical Corp Company Overview

5.18.1 Uro Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

5.19 Valencia Technologies Corp Company Overview

5.19.1 Valencia Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview

5.20 Washington University School of Medicine Company Overview

5.20.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview

6 Peripheral Nerve Stimulators (PNS)- Recent Developments

6.1 Sep 09, 2024: Neuros Medical Obtains Pre-Market Approval (PMA) Clearance for Altius Direct Electrical Nerve Stimulation System

6.2 Aug 29, 2024: Neuros Medical wins FDA approval for post-amputation pain stimulation treatment

6.3 Jul 30, 2024: Nervonik Receives Regulatory Approval to Start First-In-Human Study With Novel Peripheral Nerve Stimulation Technology for Chronic Pain

6.4 Jul 23, 2024: Neuspera Medical, Reaches Significant Milestone: Final Patient Has Completed Primary Endpoint Visit in the SANS-UUI Pivotal Clinical Trial

6.5 Jul 11, 2024: Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin Procedure

6.6 Jul 09, 2024: Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom PNS System

6.7 Jul 02, 2024: Curonix Receives 510(K) Clearance For Freedom Peripheral Nerve Stimulator (PNS) System

6.8 May 22, 2024: Landmark Study Of A Revolutionary Device For The Treatment Of Post Amputation Pain Accepted For Publication In The Journal Of Pain Research

6.9 May 02, 2024: Implantable Tibial Nerve Stimulation Added as Treatment Option within AUA/SUFU 2024 OAB Guideline

6.10 Feb 08, 2024: BlueWind launches Revi implantable device in Ohio, US

6.11 Jan 18, 2024: Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence

6.12 Jan 10, 2024: Neurolief’s neuromodulation device approved as migraine therapy in Japan

6.13 Jan 09, 2024: Anthem Blue Cross and Blue Shield Announces Coverage for the eCoin System for Urinary Incontinence

6.14 Jan 03, 2024: Cardionomic Announces Enrollment Completion in the STIM-ADHF and STOP-ADHF Pilot Studies

6.15 Nov 07, 2023: Valencia Technologies Announced Today That the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS), Published the 2024 Medicare Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems

6.16 Oct 23, 2023: Neuros medical Names David veino as president and CEO and expands board of directors

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Segment

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Territory

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Regulatory Path

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Estimated Approval Date

Peripheral Nerve Stimulators (PNS) – Ongoing Clinical Trials

Peripheral Nerve Stimulators (PNS) Companies – Pipeline Products by Stage of Development

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development

Axonic SAS Pipeline Products & Ongoing Clinical Trials Overview

Neurostimulation System – Phantom Limb Pain – Product Status

Neurostimulation System – Phantom Limb Pain – Product Description

Beijing Leading Medical Valley Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Nerve Stimulation Device – Product Status

Peripheral Nerve Stimulation Device – Product Description

Bioness Inc Pipeline Products & Ongoing Clinical Trials Overview

StimRouter – Overactive Bladder – Product Status

StimRouter – Overactive Bladder – Product Description

Talismann PNS Device – Product Status

Talismann PNS Device – Product Description

Cardionomic Inc Pipeline Products & Ongoing Clinical Trials Overview

Cardiac Pulmonary Nerve Stimulation (CPNS) System – Product Status

Cardiac Pulmonary Nerve Stimulation (CPNS) System – Product Description

Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview

INTIBIA Implantable Tibial Nerve Stimulator – Product Status

INTIBIA Implantable Tibial Nerve Stimulator – Product Description

Coloplast A/S – Ongoing Clinical Trials Overview

INTIBIA Implantable Tibial Nerve Stimulator – A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator, Through 24-Months (INTIBIA Pivotal Study IU024)

EBT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

NiNA – Product Status

NiNA – Product Description

Evonik Corp Pipeline Products & Ongoing Clinical Trials Overview

VESTAKEEP PEEK Implant – Neuromodulation – Product Status

VESTAKEEP PEEK Implant – Neuromodulation – Product Description

Hangzhou Shenluo Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Nerve Stimulation Device – Apnea – Product Status

Peripheral Nerve Stimulation Device – Apnea – Product Description

Peripheral Nerve Stimulation Device – Heart Failure – Product Status

Peripheral Nerve Stimulation Device – Heart Failure – Product Description

Peripheral Nerve Stimulation Device – Hypertension – Product Status

Peripheral Nerve Stimulation Device – Hypertension – Product Description

Peripheral Nerve Stimulation Device – Pain – Product Status

Peripheral Nerve Stimulation Device – Pain – Product Description

Peripheral Nerve Stimulation Device – Urinary Incontinence – Product Status

Peripheral Nerve Stimulation Device – Urinary Incontinence – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

Implantable Tibial Neuromodulation Device – Product Status

Implantable Tibial Neuromodulation Device – Product Description

Medtronic Plc – Ongoing Clinical Trials Overview

Implantable Tibial Neuromodulation Device – Evaluation of Implantable Tibial Neuromodulation Pivotal Study

MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview

SAINT System – Anxiety Disorders – Product Status

SAINT System – Anxiety Disorders – Product Description

SAINT System – Chronic Pain – Product Status

SAINT System – Chronic Pain – Product Description

SAINT System – Motor And Speech Deficit – Product Status

SAINT System – Motor And Speech Deficit – Product Description

SAINT System – Urinary Incontinence – Product Status

SAINT System – Urinary Incontinence – Product Description

Nervonik Inc Pipeline Products & Ongoing Clinical Trials Overview

Miniaturized Neuromodulation Device – Product Status

Miniaturized Neuromodulation Device – Product Description

Nervonik Inc – Ongoing Clinical Trials Overview

Miniaturized Neuromodulation Device – A First-in-human Feasibility Study in Utilizing the Novel Peripheral Nerve Stimulation Technology for Chronic Pain

Neurolief Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Relivion – Attention Deficit Hyperactivity Disorder – Product Status

Relivion – Attention Deficit Hyperactivity Disorder – Product Description

Relivion – Insomnia – Product Status

Relivion – Insomnia – Product Description

Neuros Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Altius System – Chronic Nerve Pain – Product Status

Altius System – Chronic Nerve Pain – Product Description

Neurostream Technologies G.P. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Neurostep – Product Status

Neurostep – Product Description

Ripple LLC Pipeline Products & Ongoing Clinical Trials Overview

Implantable Peripheral Nerve Stimulator – Product Status

Implantable Peripheral Nerve Stimulator – Product Description

SPR Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

Micropulse Peripheral Nerve Stimulation System – Product Status

Micropulse Peripheral Nerve Stimulation System – Product Description

University of Utah Pipeline Products & Ongoing Clinical Trials Overview

Utah Slanted Electrode Array – Product Status

Utah Slanted Electrode Array – Product Description

Uro Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

Protect PNS – Product Status

Protect PNS – Product Description

Uro Medical Corp – Ongoing Clinical Trials Overview

Protect PNS – Multi-center, Prospective, Randomized, Controlled, Non-Inferiority, Clinical Trial of Chronic Afferent Nerve Stimulation (CAN-Stim) of the Tibial Nerve versus Sacral Nerve Stimulation (SNS) in the Treatment of Urinary Urgency Incontinence Resulting from Refractory Overactive Bladder (OAB)

Valencia Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview

eCoin Neurostimulator – Depression – Product Status

eCoin Neurostimulator – Depression – Product Description

eCoin Neurostimulator – Erectile Dysfunction – Product Status

eCoin Neurostimulator – Erectile Dysfunction – Product Description

eCoin Neurostimulator – Heart Failure – Product Status

eCoin Neurostimulator – Heart Failure – Product Description

eCoin Neurostimulator – Obesity – Product Status

eCoin Neurostimulator – Obesity – Product Description

eCoin Neurostimulator – Osteoarthritis – Product Status

eCoin Neurostimulator – Osteoarthritis – Product Description

eCoin Neurostimulator – Pain – Product Status

eCoin Neurostimulator – Pain – Product Description

eCoin Neurostimulator – Resistant Hypertension – Product Status

eCoin Neurostimulator – Resistant Hypertension – Product Description

Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview

Biodegradable Device – Electrical Stimulation – Product Status

Biodegradable Device – Electrical Stimulation – Product Description

Glossary

Figures

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Segment

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Territory

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Regulatory Path

Peripheral Nerve Stimulators (PNS) – Pipeline Products by Estimated Approval Date

Peripheral Nerve Stimulators (PNS) – Ongoing Clinical Trials

Frequently asked questions

Peripheral Nerve Stimulators (PNS) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Peripheral Nerve Stimulators (PNS) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Peripheral Nerve Stimulators (PNS) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Peripheral Nerve Stimulators (PNS) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.